Q56.1 Male pseudohermaphroditism, not elsewhere classified

Name of the Condition

• Male pseudohermaphroditism, not elsewhere classified (ICD-10 code Q56.1)
• Also known as 46,XY DSD (Disorders of Sexual Development).

Summary

Male pseudohermaphroditism is a condition in which an individual has typical male chromosomes (46,XY) but exhibits atypical sexual differentiation, often resulting in ambiguous genitalia or underdeveloped male reproductive structures. This occurs due to disruptions in androgen production or action during fetal development.

Causes

The condition is typically caused by defects in the synthesis or action of male hormones (androgens) or their receptors. This can stem from genetic mutations affecting enzymes involved in androgen production, such as 5-alpha reductase deficiency, or abnormalities in androgen receptor function.

Risk Factors

• Genetic mutations affecting androgen synthesis or receptor function.
• Family history of disorders of sexual development.
• Maternal factors that may influence fetal hormone exposure, though specific maternal contributors are less common than in female pseudohermaphroditism.

Symptoms

• Ambiguous genitalia at birth, such as a small penis, hypospadias, or undescended testes.
• Inconsistent development of secondary sexual characteristics during puberty.
• Possible infertility or reduced fertility.

Diagnosis

Diagnosis involves a physical examination to assess genitalia, hormonal assays to evaluate androgen levels and function, genetic testing (e.g., karyotyping) to confirm 46,XY chromosomes, and imaging studies to evaluate internal reproductive structures. Biopsy of gonadal tissue may be performed if needed.

Treatment Options

• Hormonal therapy to address deficiencies or imbalances in androgen production.
• Surgical interventions to correct ambiguous genitalia or address structural abnormalities.
• Psychological support and gender-affirming care, as appropriate.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and severity of the condition. Early diagnosis and intervention can improve outcomes, including sexual function and psychological well-being. Long-term follow-up with endocrinologists and urologists is often necessary to monitor development and address complications.

Complications

• Infertility or reduced fertility.
• Psychological distress related to gender identity or body image.
• Increased risk of gonadal tumors in some cases, requiring surveillance.

Lifestyle & Prevention

There are no specific lifestyle measures to prevent male pseudohermaphroditism, as it is typically a genetic or developmental condition. Genetic counseling may be recommended for families with a history of the disorder.

When to Seek Professional Help

Seek medical evaluation if a newborn has ambiguous genitalia, or if an individual experiences delayed or atypical puberty, infertility, or concerns about sexual development.

Tips for Medical Coders

When coding Q56.1, ensure documentation supports the diagnosis of male pseudohermaphroditism with 46,XY chromosomes and atypical sexual differentiation. Include details on genitalia appearance, hormonal testing, and genetic confirmation to justify the code. Avoid using this code for conditions with specific alternative classifications (e.g., 5-alpha reductase deficiency, which may have separate codes).